Population screening for hemochromatosis: A study in 5370 Spanish blood donors

Journal of Hepatology

Volumn 38, Issue 6, 2003, Pages 745-750

  Sánchez, Mayka ^a   Villa, Margarita ^a   Ingelmo, Mercedes ^a   Sanz, Cristina ^b   Bruguera, Miquel ^a   Ascaso, Carlos ^a   Oliva, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

C282Y; H63D; Hereditary hemochromatosis; HFE gene; Iron overload

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; ALLELISM; ARTICLE; BLOOD DONOR; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; TRANSFERRIN BLOOD LEVEL;

EID: 0038578537     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00123-5     Document Type: Article

References (29)

1. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, editors. Iron metabolism in health and disease. London: Saunders, 1994. pp. 227-270.
2. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Longterm survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. Worwood M, Shearman JD, Wallace DF, Dooley LS, Merryweather-Clarke AT, Pointon LL, et al. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-844.
5. Sánchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998;29:725-728.
6. Moreno L, Vallcorba P, Boixeda D, Cabello P, Bermejo F, San Roman C. The usefulness of the detection of Cys282Tyr and His63Asp mutations in the diagnosis of hereditary hemochromatosis. Rev Clin Esp 1999;199:632-636.
7. Guix P, Picornell A, Parera M, Galmes A, Obrador A, Ramon MM, Castro JA. Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin Genet 2002;61:43-48.
8. Baiget M, Barcelo MJ, Gimferrer E. Frequency of the C282Y and H63D mutations in distinct ethnic groups living in Spain. J Med Genet 1998;35:701.
9. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-198.
10. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-832.
11. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
12. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal dominant hemochromatosis is associated with a mutation in the ferroportin (SCL11A3) gene. J Clin Invest 2001;108:619-623.
13. Sánchez M, Bruguera M, Quintero E, Marrio Y, Mazzara R, Rodés J, Oliva R. Hereditary hemochromatosis in Spain. Genet Test 2000;4:171-176.
14. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon L, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-936.
15. Fairbanks VF, Klee GG. Biochemical aspects of haematology. In: Tietz NW, Burtis CA, Ashwood ER, editors. Textbook of clinical chemistry, 2nd ed. Philadelphia, PA: Saunders, 1986. pp. 2061-2065.
16. Higuchi R. DNA from whole blood for PCR. Amplifications 1989;2:1-3.
17. Stott MK, Fellowes AP, Upton JD, Burt MJ, George PM. Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations. Clin Chem 1999;45:426-428.
18. Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis [Letter]. Nat Genet 1999;22:325-326.
19. Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998;43:830-836.
20. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LWA. Population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-724.
21. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Glummer-Stawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999;107:3037.
22. Adams PC, Kertesz AE, Mclaren CE, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000;31:1160-1164.
23. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U. et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-1115.
24. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001;114:474-484.
25. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218.
26. Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, et al. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 2001;34:523-528.
27. Aguilar-Martinez P, Thelcide C, Jeanjean P, Masmejean C, Giansily M, Schved JF. Haplotype analysis of the HFE gene: implications for the origins of hemochromatosis related mutations. Blood Cells Mol Dis 1999;25:166-169.
28. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, et al. Haemochromatosis and HLA-H [Letter]. Nat Genet 1996;14:251-252.
29. Laine F, Ropert M, Lan CL, Loreal O. Bellissant E, Jard C, et al. Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients. J Hepatol 2002;36:60-65.